Speciality: Dermatology
Description:
A warm welcome to all the medical professionals in this interesting session on Understanding Urticaria
Urticaria, commonly known as hives, is a skin condition characterized by the sudden appearance of red, itchy welts or raised areas on the skin. These welts can vary in size and may appear on any part of the body, often changing location or shape within a few hours. Urticaria is typically triggered by allergic reactions to substances like food, medications, insect stings, or even environmental factors like heat, cold, or stress.
There are two main types of urticaria: acute and chronic. Acute urticaria lasts for less than six weeks and is usually linked to a clear allergen. Chronic urticaria, on the other hand, persists for six weeks or more and often has no identifiable cause. Treatment usually involves antihistamines to reduce itching and swelling, though more severe cases may require corticosteroids or immunosuppressants. Identifying and avoiding triggers, when possible, is key to preventing flare-ups and managing the condition effectively.
Therefore, get an overall knowledge of understanding urticaria
See More Webinars @ Hidoc Webinars
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation